Atlas Trials

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Clinical trial NCT00833066 · COMPLETED

Trial details

NCT number
NCT00833066
Sponsor
BioTech Tools S.A.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Seasonal Allergic Rhinoconjunctivitis
Start date
2009-02-01
Primary completion
2009-10-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.